TITLE

Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. Rhamnosus GG

AUTHOR(S)
Salminen, Minna K.; Rautelin, Hilpi; Tynkkynen, Soile; Poussa, Tuija; Saxelin, Maija; Valtonen, Ville; Järvinen, Asko
PUB. DATE
January 2004
SOURCE
Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Lactobacillus bacteremia is a rare entity, and its clinical significance is poorly defined. We have reviewed the risk factors and outcome for 89 case patients with Lactobacillus bacteremia. Species characterization was done in 53% of the cases, revealing 25 L. rhamnosus strains and 22 other Lactobacillus species. In 11 cases, the strain was identical with the probiotic L. rhamnosus GG. In 82% of the cases, the patients had severe or fatal comorbidities. Predisposing factors to bacteremia were immunosuppression, prior prolonged hospitalization, and prior surgical interventions. No significant differences were observed in these predisposing factors or clinical features between patients with cases associated with the various Lactobacillus species, other than higher C-reactive protein values in patients with L. rhamnosus bacteremia. Mortality was 26% at 1 month and was 48% at 1 year. In multivariate analysis, severe underlying diseases were a significant predictor for mortality (odds ratio [OR], 15.8), whereas treatment with antimicrobials effective in vitro was associated with lower mortality (OR, 0.22). We conclude that lactobacilli in blood cultures are of clinical significance and that their susceptibility should guide decisions about antimicrobial treatment.
ACCESSION #
11791293

 

Related Articles

  • Risk Factors for and Estimated Incidence of Community-associated Clostridium difficile Infection, North Carolina, USA. Kutty, Preeta K.; Woods, Christopher W.; Sena, Arlene C.; Benoit, Stephen R.; Naggie, Susanna; Frederick, Joyce; Evans, Sharon; Engel, Jeffery; McDonald, L. Clifford // Emerging Infectious Diseases;Feb2010, Vol. 16 Issue 2, p197 

    We determined estimated incidence of and risk factors for community-associated Clostridium difficile infection (CA-CDI) among patients treated at 6 North Carolina hospitals. CA-CDI case-patients were defined as adults (>18 years of age) with a positive stool test result for C. difficile toxin...

  • Antibiotic use linked to MRSA risk.  // Infectious Diseases in Children;Dec2008, Vol. 21 Issue 12, p32 

    The article discusses findings of a study presented by Rosie Lyles during the 2008 Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America Meeting, which examined predictors of methicillin-resistant Staphylococcus aureus (MRSA). The study revealed...

  • Complexity and Subtlety of Infective Endocarditis. Paterick, Timothy E.; Paterick, Timothy J.; Nishimura, Rick A.; Steckelberg, James M. // Mayo Clinic Proceedings;May2007, Vol. 82 Issue 5, p615 

    Infective endocarditis (IE) is an uncommon clinical entity that, if unrecognized, leads to serious morbidity and mortality. Approximately 15,000 new cases of IE occur in the United States each year. Despite advances in early diagnosis, antimicrobial treatment, and surgical techniques, reported...

  • HIRURÅ KI PRISTUPI REVASKULARIZACIJI AORTO-ILIJAKALNOG SEGMENTA. Solaković, Emir; Totić, Dragan; Solaković, Sid // Acta Medica Saliniana;2008, Vol. 37 Issue 2, p114 

    Introduction: The retroperitoneal approach for abdominal aortic and iliac reconstruction classically had been reserved for select patients with either high-risk comorbid disease or specific anatomic problems that preclude the transabdominal approach. With increasing appreciation of the...

  • Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. Garnica, Marcia; Nouér, Simone A.; Pellegrino, Flávia LPC; Moreira, Beatriz M.; Maiolino, Angelo; Nucci, Marcio // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on quinolone resistance among patients receiving prophylaxis, with very few data reporting its impact...

  • Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Cherif, Honar; Kronvall, Göran; Björkholm, Magnus; Kalin, Mats // Hematology Journal;2003, Vol. 4 Issue 6, p420 

    Bacteraemia is a major cause of morbidity and mortality in patients with haematological disorders during chemotherapy-induced neutropenia. The generally reported trend during the last two decades has been a gradual replacement of Gram-negative bacilli by Gram-positive cocci as the major causes...

  • Staphylococcus aureus Bacteremia, Australia. Collignon, Peter; Nimmo, Graeme R.; Gottlieb, Thomas; Gosbell, Iain B. // Emerging Infectious Diseases;Apr2005, Vol. 11 Issue 4, p554 

    Staphylococcus aureus bacteremia (SAB) is common and increasing worldwide. A retrospective review was undertaken to quantify the number of cases, their place of acquisition, and the proportions caused by methicillin-resistant S. aureus (MRSA) in 17 hospitals in Australia. Of 3,192 episodes,...

  • Varicella-Related Hospitalization In Children: A Retrospective Study In The Pre-Vaccine Era In Ankara, Turkey. Belet, Nurşen; Tapısız, Anıl; Çiftçi, Ergin; İnce, Erdal; Doğru, Ülker // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Mar2009, Vol. 3 Issue 1, p1 

    Aim: Varicella is predominantly a childhood disease in non-vaccinated populations. The purpose of the study is to evaluate the indications of hospital admissions, complications of varicella infection and their clinical characteristics among previously healthy and children. with underlying...

  • Coagulase-negative staphylococcal bacteremia: risk factors for mortality and impact of initial appropriate antimicrobial therapy on outcome. Park, S.; Kwon, K.; Chung, J.-W.; Huh, H.; Chae, S. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2015, Vol. 34 Issue 7, p1395 

    It is uncertain whether an initial inappropriate empirical antibiotic treatment of coagulase-negative staphylococci (CoNS) bacteremia adversely affects the outcome. A retrospective cohort study of CoNS bacteremia was performed at the Dongguk University Ilsan Hospital during a 3-year period....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics